{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:03:30Z","timestamp":1753272210445,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.yebeh.2024.109805","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T17:34:33Z","timestamp":1714152873000},"page":"109805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Placebo response in patients with Dravet syndrome: Post-hoc analysis of two clinical trials"],"prefix":"10.1016","volume":"156","author":[{"given":"Orrin","family":"Devinsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Nortvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109805_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109805_b0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/cjn.2016.243","article-title":"Dravet syndrome: diagnosis and long-term course","volume":"43","author":"Conolly","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.yebeh.2024.109805_b0015","first-page":"60","article-title":"Infantile, childhood, and adolescent epilepsies","volume":"22","author":"Wirrell","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2024.109805_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2016.02.002","article-title":"Response to placebo in clinical epilepsy trials\u2013old ideas and new insights","volume":"122","author":"Goldenholz","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.109805_b0025","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1371\/journal.pmed.0050166","article-title":"Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy","volume":"5","author":"Rheims","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.yebeh.2024.109805_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00787-018-1244-7","article-title":"Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis","volume":"29","author":"Meister","year":"2020","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.yebeh.2024.109805_b0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000365248","article-title":"Age and sex as moderators of the placebo response \u2013 an evaluation of systematic reviews and meta-analyses across medicine","volume":"61","author":"Weimer","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.yebeh.2024.109805_b0040","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/epi.17716","article-title":"Increasing challenges to trial recruitment and conduct over time","volume":"64","author":"Kerr","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109805_b0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1528-1167.2010.02915.x","article-title":"Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis","volume":"52","author":"Rheims","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109805_b0050","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/epi.17730","article-title":"Quantifying and controlling the impact of regression to the mean on randomized controlled trials in epilepsy","volume":"64","author":"Goldenholz","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109805_b0055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMc1708349","article-title":"Trial of Cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"377","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2024.109805_b0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in dravet syndrome: a randomized clinical trial","volume":"77","author":"Miller","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2024.109805_b0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1567205043332027","article-title":"Regression to the mean: implications for clinical trials of psychotropic agents in dementia","volume":"1","author":"Cummings","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.yebeh.2024.109805_b0070","series-title":"International review of neurobiology","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/bs.irn.2020.03.033","article-title":"Chapter eleven - placebo in epilepsy","author":"Goldenholz","year":"2020"},{"key":"10.1016\/j.yebeh.2024.109805_b0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.seizure.2016.12.003","article-title":"Nocebo effect in refractory partial epilepsy during pre-monitoring: systematic review and meta-analysis of placebo-controlled clinical trials","volume":"45","author":"Zis","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.109805_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","article-title":"Highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond Dravet syndrome and Lennox-Gastaut syndrome","volume":"35","author":"Lattanzi","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.109805_b0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy\u2014a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109805_b0090","series-title":"The comorbidities of epilepsy","first-page":"131","article-title":"Chapter 7 - epilepsy and obesity: a complex interaction","author":"Ladino","year":"2019"},{"key":"10.1016\/j.yebeh.2024.109805_b0095","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2024.109805_b0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T01:22:47Z","timestamp":1738459367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":20,"alternative-id":["S1525505024001860"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109805","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placebo response in patients with Dravet syndrome: Post-hoc analysis of two clinical trials","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109805"}}